Nikita Varshneya
Cardiovascular Disease · Clark, NJNPI 1275551103
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.3% of the total across 352 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 38 manufacturers, the largest accounting for just 13.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,329 and has fallen 87.8% since, to $162 in 2024.
Across 352 payments — averaging $15.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amarin Pharma, Inc.$744
- Abbott$449
- Amgen$412
- AstraZeneca$388
- Johnson & Johnson$351
- Daiichi Sankyo Inc.$329
- plus $3K from 32 others
What the payments were for
- Food & beverage$5,30599%
- Education$361%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amarin Pharma, Inc. | 54 | $744 |
| Abbott | 8 | $449 |
| Amgen | 30 | $412 |
| AstraZeneca | 30 | $388 |
| Johnson & Johnson | 27 | $351 |
| Daiichi Sankyo Inc. | 35 | $329 |
| Merck | 21 | $292 |
| Novartis | 22 | $290 |
| Boehringer Ingelheim | 18 | $255 |
| Boston Scientific | 4 | $170 |
| E.r. Squibb & Sons, L.L.C. | 12 | $140 |
| Esperion Therapeutics, Inc. | 10 | $133 |
| Sanofi-aventis U.S. LLC | 9 | $131 |
| Irhythm Technologies, Inc. | 4 | $130 |
| Pfizer | 9 | $120 |
| Biotronik Inc. | 1 | $105 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $102 |
| Cvrx, Inc. | 3 | $96 |
| Bardy Diagnostics, Inc. | 7 | $89 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $70 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $70 |
| Nestle Healthcare Nutrition Inc. | 4 | $60 |
| Novo Nordisk | 4 | $58 |
| Bayer | 3 | $54 |
| Amryt Pharma Holdings Ltd | 3 | $48 |
| Medtronic(2 entities) | 2 | $33 |
| Althera Pharmaceuticals LLC | 2 | $31 |
| QOL Medical, LLC | 2 | $27 |
| Regeneron Healthcare Solutions, Inc. | 2 | $26 |
| Redhill Biopharma Inc. | 2 | $25 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| AbbVie | 1 | $15 |
| GSK | 1 | $14 |
| Ardelyx, Inc. | 1 | $14 |
| Seqirus USA Inc | 1 | $14 |
| Ironwood Pharmaceuticals, Inc | 1 | $14 |
| Arbor Pharmaceuticals, Inc. | 1 | $14 |
| Impulse Dynamics (USA) Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,341 in reported general payments places this provider in the 65th percentile of 1,006 cardiovascular disease providers in New Jersey.
Other cardiovascular disease in Clark
- Sheila SahniClark$109K
- Marc CohenNewark$762K
- Peter FarrugiaColts Neck$600K
- Felix Dailey-SterlingGuttenberg$568K
- Ramzan ZakirNew Brunswick$342K
- Richard KovachBrowns Mills$300K
- Andrea RussoCamden$293K
- John KostisNew Brunswick$225K
- Dilip ViswanathHaddon Heights$167K
- David PowellSpringfield$162K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.